PSNL
Personalis, Inc.
Key Financials
Operating Income
$-88057000
↓ 29.0%
Net Income
$-81270000
↑ 0.0%
Total Assets
$334.2M
↑ 23.6%
Gross Profit
$6.6M
↑ 16.6%
EPS (Diluted)
$-0.91
↑ 33.6%
Shareholders' Equity
$261.2M
↑ 28.7%
Total Liabilities
$73.0M
↑ 8.4%
Cash & Equivalents
$124.2M
↑ 35.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/4/2026 | View on SEC |
| 8-K | 8/4/2026 | View on SEC |
| SCHEDULE 13G | 7/29/2026 | View on SEC |
| SCHEDULE 13D/A | 7/21/2026 | View on SEC |
| 425 | 7/20/2026 | View on SEC |
| 8-K | 7/20/2026 | View on SEC |
| 425 | 7/20/2026 | View on SEC |
| 425 | 7/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PSNL |
| Company Name | Personalis, Inc. |
| CIK | 1527753 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-752-1300 |